- Barrenjoey raised ResMed price target to A$37.50 per share.
- The increase is 3.6% from the prior target.
Barrenjoey lifted its ResMed price target to A$37.50 per share, up 3.6%. The move reflects a modest upward revision in the broker's view, though no supporting rationale was disclosed.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.